CAJ | 학술논문

目的：探析NT-proBNP下降率对心衰疗效和再住院率的评估价值。方法选取200例心衰患者，依据NT-proBNP下降率将其分为两组，研究组NT-proBNP下降率在30%以上，对照组NT-proBNP下降率在30%以下，对比分析两组临床疗效、再住院率和死亡情况。结果研究组治疗效果良好率为87.50%，对照组为71.25%，P＜0.05，差异具有统计学意义；对两组患者随访半年，研究组再住院率为6.67%，对照组为21.25%，P＜0.05，差异具有统计学意义；研究组死亡几率1.67%，对照组为12.5%，P＜0.05，差异具有统计学意义。结论血清NT-proBNP下降率评估心衰患者的疗效及再住院率价值较高，且对判断患者预后情况具有重要的意义。
목적：탐석NT-proBNP하강솔대심쇠료효화재주원솔적평고개치。방법선취200례심쇠환자，의거NT-proBNP하강솔장기분위량조，연구조NT-proBNP하강솔재30%이상，대조조NT-proBNP하강솔재30%이하，대비분석량조림상료효、재주원솔화사망정황。결과연구조치료효과량호솔위87.50%，대조조위71.25%，P＜0.05，차이구유통계학의의；대량조환자수방반년，연구조재주원솔위6.67%，대조조위21.25%，P＜0.05，차이구유통계학의의；연구조사망궤솔1.67%，대조조위12.5%，P＜0.05，차이구유통계학의의。결론혈청NT-proBNP하강솔평고심쇠환자적료효급재주원솔개치교고，차대판단환자예후정황구유중요적의의。
Objective NT-proBNP decreased rate of heart failure efifcacy and assess the value of re-hospitalization rates. MethodsSelected 200 cases of patients with heart failure, NT-proBNP in accordance with the rate of decline will be divided into two groups of clinical efifcacy study group NT-proBNP decreased rate of 30% in the control group rate of decrease in NT-proBNP below 30%, comparative analysis , readmission rates and mortality. ResultsStudy group treatment effect good chance of 87.50% in the control group was 71.25%,P<0.05, had difference statistically significance. two groups of patients were followed up for six months, the study group readmission rate was 6.67%, the control group was 21.25%,P<0.05, had difference statistically significance. 1.67% chance of death study group, 12.5% in the control group,P<0.05, had difference statistically signiifcance. Conclusion The serum NT-proBNP decreased rate of heart failure patients to assess the efficacy and readmission rates higher value, and has great signiifcance in judging the prognosis of patients.